LifeVantage sales down 23% as GLP-1 interest cools

LifeVantage, a multi-level marketing company selling supplements, reported its revenue dropped 23.1% to $42.4 million for Q4 2026. The company specifically cited lower order volumes and a "GLP-1 system slump" as reasons for the decline. This signals a cooling in the GLP-1 supplement adjacent market, even as pharmaceutical GLP-1s surge.